Three Questions, Piet van der Graaf 2016 年 4 月 21 日 Facebook LinkedIn Twitter Facebook LinkedIn Twitter Continue to Article 関連コンテンツ PBPK Modeling to Support Bioequivalence & Generic Product Approvals ブログ Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers 論文 Certara Announces New Clinical Science Group and Adds Senior Scientific Experts プレスリリース How to Build a Firm Foundation for Your Drug Development Program ブログ
